San Diego, CA, United States of America

Aaron R Strunk


 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 253(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Aaron R. Strunk

Introduction

Aaron R. Strunk is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical technology, particularly in the area of ablation therapies. With a total of 5 patents to his name, Strunk's work has advanced the understanding and application of medical devices in clinical settings.

Latest Patents

Strunk's latest patents include the "Thermochromic Polyacrylamide Tissue Phantom and Its Use for Evaluation of Ablation Therapies." This invention features a polyacrylamide tissue phantom embedded with multi-formulated thermochromic liquid crystals. It serves as a suitable substitute for biological tissue, allowing for the evaluation of RF ablation therapies. Another significant patent is the "System and Method for Adaptive RF Ablation." This medical method and device involve a systematic approach to delivering energy to ablate tissue while ensuring continuous contact with the ablation element.

Career Highlights

Strunk is currently employed at Medtronic Ablation Frontiers LLC, where he continues to innovate in the field of medical technology. His work focuses on improving the efficacy and safety of ablation therapies, which are crucial in treating various medical conditions.

Collaborations

Throughout his career, Strunk has collaborated with talented individuals such as Alex Novichenok and Catherine R. Condie. These collaborations have further enriched his work and contributed to the development of advanced medical technologies.

Conclusion

Aaron R. Strunk's contributions to medical technology through his innovative patents and collaborations highlight his importance in the field. His work continues to pave the way for advancements in ablation therapies, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…